DAX-1, as an androgen-target gene, inhibits aromatase expression: a novel mechanism blocking estrogen-dependent breast cancer cell proliferation

Leptin Mediates Tumor-Stromal Interactions That Promote the Invasive Growth of Breast Cancer Cells

(2012) I. Barone et al.   CANCER RESEARCH

Chenodeoxycholic acid through a TGR5-dependent CREB signaling activation enhances Cyclin D1 expression and promotes human endometrial cancer cell proliferation

(2012) Ivan Casaburi et al.   CELL CYCLE

Estrogen receptor beta (ERβ) produces autophagy and necroptosis in human seminoma cell line through the binding of the Sp1 on the phosphatase and tensin homolog deleted from chromosome 10 (PTEN) promoter gene

(2012) Carmela Guido et al.   CELL CYCLE

Estrogens and PTP1B Function in a Novel Pathway to Regulate Aromatase Enzymatic Activity in Breast Cancer Cells

(2012) Ines Barone et al.   ENDOCRINOLOGY

Inhibition of leydig tumor growth by farnesoid X receptor activation: Thein vitroandin vivobasis for a novel therapeutic strategy

(2012) Stefania Catalano et al.   INTERNATIONAL JOURNAL OF CANCER

Omega-3 PUFA ethanolamides DHEA and EPEA induce autophagy through PPARγ activation in MCF-7 breast cancer cells

(2012) Daniela Rovito et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Nandrolone and stanozolol induce leydig cell tumor proliferation through an estrogen-dependent mechanism involving IGF-I system

(2011) Adele Chimento et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Coordinated expression of oestrogen and androgen receptors in HER2-positive breast carcinomas: impact on proliferative activity

(2011) Francini de Mattos Lima Lin et al.   JOURNAL OF CLINICAL PATHOLOGY

Expression of nuclear receptor DAX-1 and androgen receptor in human breast cancer

(2011) Byung Joo Chae et al.   JOURNAL OF SURGICAL ONCOLOGY

Expression of androgen receptor in breast cancer and its significance as a prognostic factor

(2010) Q. Yu et al.   ANNALS OF ONCOLOGY

Androgen receptor expression is a significant prognostic factor in estrogen receptor positive breast cancers

(2010) Isabella Castellano et al.   BREAST CANCER RESEARCH AND TREATMENT

Increased intratumoral androgens in human breast carcinoma following aromatase inhibitor exemestane treatment

(2010) Kiyoshi Takagi et al.   ENDOCRINE-RELATED CANCER

Inhibition of cyclin D1 expression by androgen receptor in breast cancer cells--identification of a novel androgen response element

(2010) M. Lanzino et al.   NUCLEIC ACIDS RESEARCH

Expression of androgen receptors in primary breast cancer

(2009) S. Park et al.   ANNALS OF ONCOLOGY

Cancer Statistics, 2009

(2009) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Androgen Receptor Inhibits Estrogen Receptor-  Activity and Is Prognostic in Breast Cancer

(2009) A. A. Peters et al.   CANCER RESEARCH

Nuclear Receptor DAX1 in Human Prostate Cancer: A Novel Independent Biological Modulator

(2009) Yasuhiro NAKAMURA et al.   ENDOCRINE JOURNAL

Akt2 Inhibition Enables the Forkhead Transcription Factor FoxO3a To Have a Repressive Role in Estrogen Receptor   Transcriptional Activity in Breast Cancer Cells

(2009) C. Morelli et al.   MOLECULAR AND CELLULAR BIOLOGY

In situestrogen production and its regulation in human breast carcinoma: From endocrinology to intracrinology

(2009) Hironobu Sasano et al.   PATHOLOGY INTERNATIONAL

Insulin receptor substrate 1 modulates the transcriptional activity and the stability of androgen receptor in breast cancer cells

(2008) Marilena Lanzino et al.   BREAST CANCER RESEARCH AND TREATMENT

A cross-talk between the androgen receptor and the epidermal growth factor receptor leads to p38MAPK-dependent activation of mTOR and cyclinD1 expression in prostate and lung cancer cells

(2008) Anna Grazia Recchia et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial

(2008)   LANCET ONCOLOGY

Estrogen and its receptors in cancer

(2008) George G Chen et al.   MEDICINAL RESEARCH REVIEWS